America's drug shortage list is not a crisis — it's infrastructure

The FDA shortage list currently carries 68 drugs across 1,113 tracked presentations. Nearly three-quarters are injectables. Fentanyl and atropine injections have been on the list since January 2012. A shortage that survives 14 years of weekly checks is not an emergency — it is how the supply works now.

Published 2026-11-12Data FDA drug shortage registry, status=Current (1,113 rows, 68 drugs), pulled 2026-11-12Read 8 min

The short version

The FDA shortage list currently tracks 68 drugs across 1,113 presentations — and 74% of them are injectables: lidocaine 65 rows, bupivacaine 57, dexmedetomidine 56, carboplatin 29. ADHD medications are fragmented across 219 rows and 24 manufacturers. The oldest entries — fentanyl and atropine injections — have been listed since January 2012. Eight hundred fourteen of the rows carry a "reverified" stamp from this cycle: the list is checked week after week, which makes it a standing condition, not a crisis.

To look up a specific presentation, rerun the registry query yourself — the full list moves weekly.

The list measures fragility, not emergencies

The FDA drug shortage registry logs every presentation — drug plus strength plus form — that a manufacturer reports as constrained, plus every one FDA verifies independently. The current list holds 1,113 rows covering 68 distinct drugs.

Shortage rows concentrate in injectable forms, and the biggest row counts are ADHD drugs and anesthetics.

A row is not a scandal. Each row is one presentation the FDA re-checks on a schedule — 814 of the current rows carry a reverified stamp from the latest cycle. What the list measures is which parts of the supply are structurally fragile, and the answer is pointed: injectable sterile drugs, where manufacturing is harder, margins are thinner, and one failed quality lot removes supply for months.

By dosage form: 820 injectable rows (73.7%), 260 oral, 33 other. Sterile injectables were also the failure mode of the recall side of this series — the same manufacturing difficulty that makes sterile drugs prone to contamination recalls makes them prone to shortages, because a quality failure and a supply gap are the same event seen from two directions.

Find your drug: the 4 groups

If you are here for a specific drug, the current list clusters into four groups:

Surgery and anesthesia (375 rows, 10 drugs). Lidocaine 65 rows, bupivacaine 57, dexmedetomidine 56, ropivacaine 49, midazolam 30, hydromorphone 26, morphine 24, fentanyl 20, etomidate 18, remifentanil 9. Hospital pharmacy teams have been managing this group continuously since 2017.

ADHD (219 rows, 5 drugs, 24 manufacturers). Lisdexamfetamine 108 rows — capsules 90, chewables 18 — mixed amphetamine salts 73, methylphenidate extended-release 38 plus film 4. This is the most fragmented group on the list — and the most confusing, because availability differs by strength and manufacturer.

Chemotherapy (about 65 rows). Carboplatin 29 rows — 12 unavailable, 8 limited, 9 available. Methotrexate injection 15, ifosfamide 8, azacitidine 9. Cisplatin, the headline shortage of 2023, is no longer on the list — recovered, not forgotten.

Emergency and critical care (65 rows). Atropine 17, plus epinephrine combination products. Naloxone is not currently listed.

The full list — every drug, row count and availability state (A=available, U=unavailable, L=limited):

drug (68 on the current list)RowsA/U/LForm
lisdexamfetamine capsule9057/0/33oral
mixed amphetamine salts tablet7344/19/10oral
lidocaine HCl injection6543/21/1inj
bupivacaine HCl injection5743/9/5inj
dexmedetomidine HCl injection5645/10/1inj
ropivacaine HCl injection4933/13/3inj
dextrose 5% injection3625/2/9inj
methylphenidate HCl (extended)3416/6/12oral
midazolam HCl injection3018/9/3inj
carboplatin injection299/12/8inj
furosemide injection2716/11/0inj
hydromorphone HCl injection2615/8/3inj
bupivacaine Hydrochloride, epinephrine Bitartrate injection2616/9/1inj
rocuronium injection2623/2/1inj
ketorolac injection2512/12/1inj
morphine Sulfate injection2416/6/2inj
methylprednisolone acetate injection237/7/9inj
epinephrine + Lidocaine HCl injection229/7/6inj
fentanyl injection2012/5/3inj
dexamethasone injection1915/4/0inj
etomidate injection1813/5/0inj
lisdexamfetamine (extended)1818/0/0oral
atropine Sulfate injection1710/6/1inj
clindamycin injection1710/4/3inj
quinapril HCl tablet164/12/0oral
amino-acid (TPN) injection1613/3/0inj
sodium acetate injection1513/1/1inj
methotrexate Sodium injection159/4/2inj
dextrose 10% injection136/1/6inj
sterile water injection139/3/1inj
dopamine HCl injection117/3/1inj
sodium bicarbonate injection117/1/3inj
lorazepam injection112/4/5inj
dobutamine HCl injection109/1/0inj
promethazine HCl injection105/4/0inj
rifampin capsule95/4/0oral
remifentanil HCl injection95/4/0inj
sterile water irrigation94/4/1other
azacitidine injection94/4/1inj
liraglutide injection96/0/3inj
heparin Sodium injection83/3/2inj
ifosfamide injection85/2/1inj
quinapril/HCTZ tablet63/3/0oral
cromolyn Sodium concentrate64/0/2other
meperidine HCl injection66/0/0inj
cefotaxime Sodium powder62/4/0other
flurazepam HCl capsule64/2/0oral
dextrose 70% injection44/0/0inj
metronidazole injection41/1/2inj
sufentanil injection40/3/1inj
penicillin G benzathine injection41/1/2inj
methylphenidate (extended)44/0/0oral
riluzole oral susp43/1/0oral
desmopressin spray40/3/1other
rifampin injection30/2/1inj
tc-99m PYP kit injection30/2/1inj
dextrose 50% injection30/1/2inj
furosemide Oral Solution33/0/0oral
valproate Sodium injection21/1/0inj
propranolol HCl injection20/2/0inj
streptozocin powder21/1/0other
hydroxocobalamin injection20/1/1inj
echothiophate iodide ophthalmic11/0/0other
bacitracin ophthalmic10/1/0other
pentostatin injection10/1/0inj
conivaptan HCl injection10/1/0inj
triamcinolone hexacetonide injection11/0/0inj
isocarboxazid tablet10/0/1oral

The groups above are where the rows concentrate; the table is where a specific name is. If your drug is not on it, it is not on the FDA current list as of 2026-11-12.

The Available-rows problem: listed does not mean unfillable

Seventy-five of the lisdexamfetamine rows are marked Available — yet they sit on the shortage list. That is not a contradiction; it is the list's actual definition. A drug stays listed while its supply is judged fragile: one manufacturer still out, demand shifted to fewer suppliers, or the FDA still verifying recovery. On this list means "watch this presentation," not "you cannot fill this prescription." The patient-facing version of that is: the same drug name can be fillable at one pharmacy and unfillable at the next, because they buy from different suppliers.

Shortage entries by year first posted: 406 rows predate 2020, 77 date to 2012.

Fourteen years on the list: fentanyl and atropine

The 1,003 current rows that carry a first-posted date span 2012 to 2026. The 2012 entries — 77 rows — include fentanyl citrate injection and atropine sulfate injection, both still listed, fourteen years later. 46% of the list predates 2020. These entries survive roughly fifty re-verification cycles a year, every year, without resolving.

That is why "shortage" is the wrong mental model. A shortage ends. This list behaves like a chronic condition: entries resolve slowly, new ones arrive, and the mix drifts toward products where few manufacturers hold sterile-fill capacity and margins do not attract new entrants. The list's own reason field mostly declines to explain: 678 of 1,113 rows (61%) cite no reason at all. Where reasons exist, demand increase leads (126), then active-ingredient shortage (61), manufacturing discontinuation (46), shipping delay (21), GMP-compliance requirements (14).

What this list cannot tell you

  • When your drug recovers. Almost no row carries an ETA; the list states current supply state, not forecasts.
  • Why, in most cases. The empty reason field is an upstream data gap, not a mystery to solve.
  • Prices. The list tracks availability, not what a scarce drug costs once it is scarce.
  • Anything outside the US registry. Other regulators run their own lists; a drug can be listed here and unlisted elsewhere.
Which drugs are currently in shortage in the US?
The current FDA list tracks 68 drugs across 1,113 presentations — largest groups: surgical anesthetics (lidocaine, bupivacaine, dexmedetomidine, ropivacaine), ADHD medications (lisdexamfetamine, mixed amphetamine salts, methylphenidate), the chemotherapy carboplatin, and critical-care injectables (fentanyl, atropine, midazolam). The full 68-name table is in the body above.
Is fentanyl still in shortage?
Fentanyl citrate injection has been on the FDA shortage list since January 2012 — fourteen years — with 20 rows currently tracked. This concerns the injectable form used in hospitals; it is unrelated to illicit fentanyl powder.
Why is my ADHD medication hard to fill?
ADHD drugs are the most fragmented group on the list: 219 rows across 24 manufacturers, with availability differing by strength and manufacturer — 75 lisdexamfetamine rows are marked available while 33 are limited. The supply is fragile rather than absent; which presentation you can fill depends on which supplier your pharmacy buys from.
How long does a drug shortage last?
It varies more than the headlines suggest: the median current entry was first posted in 2022–2023, but 406 current rows predate 2020 and 77 date to 2012. Entries are re-verified weekly (814 stamps in the latest cycle) and leave the list only when FDA verifies recovered supply.
Does a drug on the shortage list mean pharmacies can't fill it?
No. "Current" on the list means the supply chain for that presentation is judged fragile — 680 of 1,113 rows are marked available, 276 unavailable, 154 limited. Availability also differs by supplier: the same drug can be fillable at one pharmacy and not at another.
Data notes
  • Source: FDA drug shortage registry via the agentdata SDK, pulled 2026-11-12; status=Current 1,113 rows covering 68 distinct drug names, plus 59 resolved and 426 discontinued rows for context.
  • A row is one drug-presentation (name + strength + form). Row counts overstate distinct drugs; 68 is the distinct-name count.
  • Dosage-form split (injectable 820 / oral 260 / other 33) uses a regex over the dosage-form and drug-name fields; the grouping is ours, not FDA's.
  • availability as pulled: Available 680, Unavailable 276, Limited Availability 154 (plus two spelling variants and one row carrying a June-2027 recovery estimate, which we did not normalize).
  • shortage_reason is empty on 678 of 1,113 rows (61%); reason counts above are of populated fields only.
  • first_posted strings mix mm/dd/yyyy and dd/mm/yyyy across eras; year bucketing uses the trailing four digits, which is invariant.
  • This article describes registry data, not clinical guidance; for patient-facing advice the FDA's shortage FAQ is the canonical reference.
LIVE · API / MCP
Check the shortage list yourself

The full registry — every presentation, availability flag and reason field — is one query. Sign up free and look up the drug you fill, dispense or buy, then re-check it next month: the list moves weekly.